News for 'ICMR'

1 more Nipah case found in Kerala, govt to ramp up testing

1 more Nipah case found in Kerala, govt to ramp up testing

Rediff.com15 Sep 2023

A 39-year-old man tested positive for the Nipah virus, which was transmitted to him through direct contact with an infected person who died on August 30, State Health Minister Veena George said in Kozhikode on Friday.

Influenza A subtype behind rise in cough, fever cases across country

Influenza A subtype behind rise in cough, fever cases across country

Rediff.com4 Mar 2023

The H3N2, which has been in wide circulation for the past two-three months, causes more hospitalisations than other subtypes, said ICMR scientists who keep a close watch on ailments caused by respiratory viruses through the Virus Research and Diagnostic Laboratories network.

Covid third wave likely to be less severe than second: ICMR

Covid third wave likely to be less severe than second: ICMR

Rediff.com16 Jul 2021

Earlier this week, the top doctors' body in the country, the Indian Medical Association, said the third wave is "inevitable and imminent", pointing out that "in many parts of the country both the government and public are complacent and engaged in mass gatherings without following Covid protocols".

Govt in talks with SII for Nipah antibody, may put imports on hold

Govt in talks with SII for Nipah antibody, may put imports on hold

Rediff.com21 Sep 2023

Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.

Nipah variant in Kerala is from B'desh, less infectious

Nipah variant in Kerala is from B'desh, less infectious

Rediff.com13 Sep 2023

One of those infected with the virus was a nine-year-old boy.

Younger more affected by Covid as they're going out: ICMR

Younger more affected by Covid as they're going out: ICMR

Rediff.com11 May 2021

In response to a question on whether younger population were getting more affected, Indian Council of Medical Research Director General Dr Balram Bhargava said the comparison of data during the first and the second wave of COVID-19 has shown that there is not much age difference.

Nipah situation not as scary as in 2018, says K K Shailaja

Nipah situation not as scary as in 2018, says K K Shailaja

Rediff.com14 Sep 2023

Shailaja, who had won accolades for containing the Nipah infection effectively in 2018, said the southern state has a protocol and standard operating procedure (SOP) to effectively fight the infection and prevent its spread.

Health sector allocation hiked by 13% in Union Budget

Health sector allocation hiked by 13% in Union Budget

Rediff.com1 Feb 2023

The health sector has been allocated Rs 89,155 crore in the Union Budget 2023-24, a hike of around 13 per cent over Rs 79,145 crore allocated in 2022-23, with the government also announcing a mission to eliminate sickle cell anaemia by 2047.

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Rediff.com20 Dec 2023

The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

Rediff.com27 Jul 2022

The National Institute of Virology (NIV) in Pune under the ICMR has isolated the monkeypox virus from the clinical specimen of a patient, which can pave the way for development of diagnostic kits and vaccines against the disease, officials said on Wednesday.

SC to hear on Tuesday plea against donor gamete rules for surrogacy

SC to hear on Tuesday plea against donor gamete rules for surrogacy

Rediff.com29 May 2023

A plea has been filed in the Supreme Court challenging the rules issued by the Union health ministry which prohibit donor gametes to couples desirous of having children through surrogacy on the ground that it frustrates the provisions of the Surrogacy (Regulation) Act, 2021, which gives the right of parenthood to infertile couples.

Monkeypox outbreak: Govt alerts agencies, asks them to keep vigil

Monkeypox outbreak: Govt alerts agencies, asks them to keep vigil

Rediff.com20 May 2022

The Union health ministry has also directed airport and port health officers to be vigilant, they said.

Siddharth stuns sixth seed Sheng in Odisha Open

Siddharth stuns sixth seed Sheng in Odisha Open

Rediff.com26 Jan 2022

Tasnim Mir, who earlier this month became the first Indian to claim world number one status in the U-19 category, beat Keyura Mopati 13-21, 21-14, 21-19 to set up a second round clash against Malvika Bansod.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Govt utilising Covid-19 experience to tackle monkeypox: Mandaviya

Govt utilising Covid-19 experience to tackle monkeypox: Mandaviya

Rediff.com2 Aug 2022

Till date eight cases of the disease have been detected in India, out of which five have foreign travel history, the minister of health and family welfare said.

Amid rising H3N2 cases, Centre asks states to be alert

Amid rising H3N2 cases, Centre asks states to be alert

Rediff.com10 Mar 2023

From January 2 to March 5, 451 cases of H3N2 have been reported in the country, according to data shared by the health ministry.

In letter to states, Centre flags decline in Covid testing

In letter to states, Centre flags decline in Covid testing

Rediff.com18 Jan 2022

In a letter to states and UTs on Monday, Additional Secretary in the Union Health Ministry Arti Ahuja advised them to pay attention to this aspect immediately and increase the testing in a strategic manner keeping in view the trend of case positivity in specific areas.

Govt launches web portal for COVID vaccine development

Govt launches web portal for COVID vaccine development

Rediff.com28 Sep 2020

The National Clinical Registry for COVID-19 will collect systematic data on clinical signs and symptoms, laboratory investigations, management protocols, the clinical course of COVID-19, disease spectrum and outcomes of patients.

COVID-19 test kits should be made available at lowest cost: HC

COVID-19 test kits should be made available at lowest cost: HC

Rediff.com26 Apr 2020

Justice Najmi Waziri issued the direction to three private companies which had entered into an agreement to import 10 lakh test kits from China and distribute them here at a cost of Rs 600 each, the rate approved by the Indian Council of Medical Research (ICMR).

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

Rediff.com6 Oct 2020

The 'antisera' has been developed by the ICMR in collaboration with a Hyderabad-based bio-pharmaceutical firm. "With Biological E Limited we have developed an horse 'antisera' and we have just got clearance for conducting clinical trials for that," ICMR Director General Dr Balram Bhargava said at press briefing.

Yeh Hai India: Drone Delivers Vaccine

Yeh Hai India: Drone Delivers Vaccine

Rediff.com5 Oct 2021

In a first of its kind, the Indian Council of Medical Research, ICMR, delivered COVID-19 vaccines via drone from the Bishnupur District Hospital to Karang island in Loktak lake in Manipur, a distance of 26 kilometres.

Rs 245 kit from China sold to ICMR at Rs 600, says Cong

Rs 245 kit from China sold to ICMR at Rs 600, says Cong

Rediff.com28 Apr 2020

Congress leader Rahul Gandhi said nobody could imagine one would profiteer from the immeasurable suffering of millions, saying the 'scam was an insult to every Indian'.

Govt downplays NYT article criticising PM over Covid

Govt downplays NYT article criticising PM over Covid

Rediff.com16 Sep 2021

The article claimed that the "ICMR tailored its findings to fit Prime Minister Narendra Modi's optimistic narrative despite a looming crisis".

Amid heatwave, Centre to rush teams to UP, Bihar

Amid heatwave, Centre to rush teams to UP, Bihar

Rediff.com20 Jun 2023

The health minister said the Centre has taken timely measures ahead of the summer season to address heatwave-related illnesses.

Delhi monkeypox patient attended stag party in Manali

Delhi monkeypox patient attended stag party in Manali

Rediff.com24 Jul 2022

The Centre on Sunday held a high-level review meeting after a 34-year-old man from the national capital with no history of foreign travel tested positive for the monkeypox virus, making it the fourth case of the disease reported in India.

Centre to hold meet amid massive Covid spike in China, elsewhere

Centre to hold meet amid massive Covid spike in China, elsewhere

Rediff.com21 Dec 2022

The minister will review the COVID-19 situation at 11:30 am on Wednesday 'considering the international scenario', they said.

Remdesivir didn't cut mortality in Covid patients: WHO

Remdesivir didn't cut mortality in Covid patients: WHO

Rediff.com16 Oct 2020

The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Final analysis: Covaxin 65.2% effective against Delta variant

Final analysis: Covaxin 65.2% effective against Delta variant

Rediff.com3 Jul 2021

Bharat Biotech's Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

1 Bengaluru Covid sample 'different' from Delta variant: Health minister

1 Bengaluru Covid sample 'different' from Delta variant: Health minister

Rediff.com29 Nov 2021

The minister said he was not supposed to say anything officially as he was still in touch with the union health ministry and the ICMR officials.

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

Rediff.com28 Dec 2022

According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.

COVID-19: How The RAT Can Help

COVID-19: How The RAT Can Help

Rediff.com2 Feb 2022

'Serial testing is much more valuable than a single test which reflects just a point in time.'

Molnupiravir not to be included in Covid treatment now

Molnupiravir not to be included in Covid treatment now

Rediff.com11 Jan 2022

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.

Maharashtra, Rajasthan not to allow sale of Ramdev's Coronil

Maharashtra, Rajasthan not to allow sale of Ramdev's Coronil

Rediff.com25 Jun 2020

While Maharashtra Home Minister Anil Deshmukh warned the yoga guru that the state government won't allow the sale of 'spurious' medicines, Rajasthan Health Minister Raghu Sharma also said that the state government will not allow the sale of Patanjali's Ayurvedic formulation.

Maha slashes charges for COVID-19 tests by private labs

Maha slashes charges for COVID-19 tests by private labs

Rediff.com13 Jun 2020

Maharashtra Health Minister Rajesh Tope said the lowering of rates for the tests would provide a relief to the people.

Delhi L-G overrules Kejriwal's order to reserve hospitals for locals

Delhi L-G overrules Kejriwal's order to reserve hospitals for locals

Rediff.com8 Jun 2020

The move may trigger a confrontation between the AAP dispensation and the LG office.

India cancels orders for Chinese COVID-19 test kits

India cancels orders for Chinese COVID-19 test kits

Rediff.com27 Apr 2020

India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.

Licences of 2 importers supplying rapid test kits cancelled

Licences of 2 importers supplying rapid test kits cancelled

Rediff.com1 May 2020

The central drug regulator has issued show cause notices to these two importers and asked to stop the import of rapid test kits based on the observation by the apex health research body Indian Council of Medical Research (ICMR).

3 Diet Changes For A Healthy Heart

3 Diet Changes For A Healthy Heart

Rediff.com29 Sep 2023

Lack of sleep, unhealthy eating habits, physical inactivity and a stressful daily schedule stemming from demanding career paths to juggling multiple hats on the personal front are some factors that increase health challenges, especially in young Indians, notes dietician Sheryl Salis.

COVID-19 test should not cost more than Rs 4,500: Govt

COVID-19 test should not cost more than Rs 4,500: Govt

Rediff.com22 Mar 2020

This may include Rs 1,500 as a screening test for suspect cases and an additional Rs 3,000 for confirmation test, the guidelines said.